Russell Investments Group
TBIO

Russell Investments Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Russell Investments Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,673
Closed -$155K – 3360
2021
Q1 		$155K Sell
9,673
-17,400
-64% -$396K ﹤0.01% 2892
2020
Q4 		$502K Sell
27,073
-10,055
-27% -$180K ﹤0.01% 2426
2020
Q3 		$505K Buy
37,128
+6,543
+21% +$101K ﹤0.01% 2390
2020
Q2 		$548K Buy
+30,585
New +$461K ﹤0.01% 2350

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Investments Group's TBIO Position: Q2 2021 in Review

Russell Investments Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 9,673 shares — an estimated $155K sold.

Russell Investments Group first reported a position in TBIO in Q2 2020 and held it in 4 quarters. The position peaked at $548K in Q2 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Russell Investments Group reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 9,673 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $155K.
  • Russell Investments Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Russell Investments Group's Translate Bio, Inc. Common Stock position peaked at $548K in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.